Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

"This new study provides real-world evidence for its impact on Alzheimer's disease, even though preclinical research has ...

Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Members of the family behind Medline — a massive medical supply and equipment company based in Northfield — have donated $25 ...

Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate ...